Maria Svensson, MD

Maria Svensson, MD, Lund University, discusses the growing interest in checkpoint inhibitor blockade treatments for gastrointestinal cancers. In the past, there have been promising results with this treatment in metastatic disease.

Maria Svensson, MD, Lund University, discusses the importance of biomarkers in the field of gastric cancers. In a recent study, she used evidence of mismatch repair to determine prognosis of the patients.

Maria Svensson, MD, Lund University, discusses associations of PD-1 and PD-L1 expression with mismatch repair status and prognosis in chemoradiotherapy-na&iuml;ve esophageal and gastric adenocarcinoma.<br /> &nbsp;